News & Analysis on Clinical Trial Services & Contract Research And Development
The second draft of Excipact, a set of certification standards for drug excipient producers being developed by the EFCG, FECC, IPEC and PQD, has been sent to industry stakeholders for consultation.
Grifols is to sell a facility as part of a US FTC consent agreement that, if approved, will allow it to buy Talecris Biotherapeutics.
Strong first quarter performance at the packaging unit helped West beat expectations but there were CZ and Delivery Systems disappointments.
Strides’ oncology plant in Bangalore, India has been approved by the FDA, positioning the company to enter the US market.
Scientists at Eindhoven’s University of Technology (TU/e) say their new ‘spinning disc reactor’ increases the safety and efficiency of chemical production processes.
US-based Pharmaceutics International, a contract development and manufacturing organization has added an MG2 G140 capsule filler to its oral manufacturing area.
Omnicare Clinical Research (CR) has become the latest CRO to be acquired by a private equity (PE) firm.
Clinical Trial and Consulting Services (CTI) has set up a new office in Spain, citing growing industry demand for clinical research in the country.